| corporate name: |
Yantai Dongcheng Pharmaceutical Group Co., Ltd |
| English name of the company: |
Yantai Dongcheng Biochemicals Co.,Ltd. |
| Listed market: |
Shenzhen Stock Exchange |
Listing date: |
2012-05-25 |
| Issue price: |
twenty-six |
Lead underwriter: |
Minsheng Securities Co., Ltd |
| Date of establishment: |
1998-12-31 |
Registered capital: |
824.596 million yuan (CNY) |
| Organization type: |
other |
Organizational form: |
Private relative holding enterprises |
| Secretary of the Board of Directors: |
Liu Xiaojie |
Company Tel.: |
0535-6371119 |
| Secretary of the Board Tel: |
0535-6371119 |
Company Fax: |
0535-6371119 |
| Fax: |
0535-6371119 |
Company E-mail: |
stock@dcb-group.com |
| Email of the Secretary: |
stock@dcb-group.com |
Company website: |
http://www.dcb-group.com |
| Postal Code: |
two hundred and sixty-four thousand and six |
Information disclosure website: |
|
| History of renaming of securities abbreviation: |
Dongcheng Pharmaceutical |
| Registered address: |
No. 7, Changbaishan Road, Yantai Economic and Technological Development Zone, Shandong Province |
| Office address: |
No. 7, Changbaishan Road, Yantai Economic and Technological Development Zone, Shandong Province |
| Company Profile: |
The company's predecessor, Yantai Dongcheng Biochemical Co., Ltd., was established on December 31, 1998. On December 27, 2007, with the approval of the Ministry of Commerce of the People's Republic of China (SZP [2007] No. 2009), Yantai Dongcheng Biochemical Co., Ltd. established a limited liability company by means of overall change. On December 27, 2007, the company was registered with Shandong Administration for Industry and Commerce, and received a registration number of 370600400006926, with a registered capital of 40 million yuan.
In June 2014, the company name was changed from "Yantai Dongcheng Biochemical Co., Ltd." to "Yantai Dongcheng Pharmaceutical Group Co., Ltd.". |
| Main business: |
R&D, production and sales of heparin sodium and chondroitin sulfate. |
